Literature DB >> 25990127

Hypomagnesemia and isoproterenol cardiomyopathies: Protection by probucol.

A H Atrakchi1, S Bloom2, B F Dickens1, I T Mak1, W B Weglicki1.   

Abstract

Chronic magnesium deficiency is associated with injury of heart muscle, blood vessels, and neuronal tissue. Despite its clinical significance, the mechanism of magnesium deficiency-induced damage remains unclear. The myocardial necrosis induced by injecting catecholamines, which is augmented by magnesium deficiency, is thought to involve a free radical component through catecholamine autoxidation. α-tocopherol was shown to ameliorate the myocardial necrosis induced by magnesium-deficiency (Freedman et al. BBRC 1990;170:1102-1106), suggesting a role for free radicals in this process. If free-radical injury plays a role in magnesium deficiency, then the catecholamine-associated free-radical production may explain the synergistic myocardial injury between catecholamine and magnesium deficiency. To test the hypothesis that free-radical damage may play a role in magnesium deficiency-induced myocardial necrosis, we investigated the protective effects of probucol, a hypolipidemic agent with antioxidant properties. Hamsters were fed a Mg-deficient diet for 14 days with or without probucol. At the end of this period, some animals were sacrificed, while others were injected with isoproterenol and killed 48 hours later. All hearts were processed for morphometric analysis of the lesions. Changes in serum lipids were also determined. Probucol reduced the size and number of both the isoproterenol- and magnesium deficiency-induced cardiac lesions. Our results suggest that it is probucol's antioxidant property and not its hypolipidemic action that is responsible for this protection.
Copyright © 1992. Published by Elsevier Inc.

Entities:  

Year:  1992        PMID: 25990127     DOI: 10.1016/1054-8807(92)90019-K

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  6 in total

1.  The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction.

Authors:  William B Weglicki; Jay H Kramer; Christopher F Spurney; Joanna J Chmielinska; I Tong Mak
Journal:  Can J Physiol Pharmacol       Date:  2012-05-30       Impact factor: 2.273

2.  Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition.

Authors:  I T Mak; B F Dickens; A M Komarov; T L Wagner; T M Phillips; W B Weglicki
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

3.  Mg supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress, and cardiac dysfunction in rats.

Authors:  I Tong Mak; Jay H Kramer; Xi Chen; Joanna J Chmielinska; Christopher F Spurney; William B Weglicki
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-18       Impact factor: 3.619

4.  Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency.

Authors:  W B Weglicki; R E Stafford; B F Dickens; I T Mak; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

5.  Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition.

Authors:  W B Weglicki; I T Mak; R E Stafford; B F Dickens; M M Cassidy; T M Phillips
Journal:  Mol Cell Biochem       Date:  1994-01-26       Impact factor: 3.396

Review 6.  The nerve-heart connection in the pro-oxidant response to Mg-deficiency.

Authors:  Maria Isabel Tejero-Taldo; Jay Harlan Kramer; Iu Tong Mak; Andrei M Komarov; William Bernard Weglicki
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.654

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.